ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,554Top JournalReview JournalHybrid

Drug Discovery Today

Acronym:drudis
•
Abbreviation (ISO):DRUG DISCOVERY TODAY
•
Identifier (ISSN):1359-6446(Print)/1878-5832(Online)
•
Publisher:Elsevier Ltd
Clarivate IF (2026)
8.7↑ +1.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Drug Discovery Today

WoS Q1
479126.8520186.8820197.3220207.8520218.3720227.420236.520247.520258.72026
Annual Impact Factor Metric
Current (2026):8.7
Scopus SJR & RankScopus Q1
1.927
#1,554

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
235

235 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate3.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
266articles/year
34.32% Gold OA•0% Original Research

Aims & Scope

Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed. Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports. Coverage includes: • Novel therapeutic strategies • High-throughput screening • Therapeutic targets • Combinatorial chemistry, parallel synthesis and library design • Drug delivery • ADME/Tox • Advances in key compound classes and therapeutic areas • Genomics and proteomics • Automation and technology • Virtual chemistry • Informatics • Business strategy • Clinical trials and other aspects of drug discovery.

Topics Covered (Recognized by AI)
BiologyChemistryMedicineBiochemistryPharmacologyComputational BiologyBioinformaticsGeneticsInternal MedicinePathologyComputer SciencePsychologyPsychiatryEngineeringPhysicsNursing
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank17/356
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank74/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF8.7
Articles / Year221
Total Citations202
2025
IF7.5
Articles / Year285
Total Citations1,751
2024
IF6.5
Articles / Year275
Total Citations4,843
2023
IF7.4
Articles / Year266
Total Citations6,398
2022
IF8.369
Articles / Year253
Total Citations9,009

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,554Scopus Q1SCImago Profile
Scopus Coverage:1996-2026
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.927

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
8.80

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,641 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations7,914
3-Year Documents851
Citable Documents807

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)4

Citations in government and international policy documents

Female Author Rate38.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ1
PharmacologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Drug Discovery Today (acronym: drudis, abbr: DRUG DISCOVERY TODAY, ISSN: 1359-6446) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Ltd in England since 1996. The periodical holds a Journal Impact Factor (JIF) of 8.70, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.927 (Q1), an H-index of 235.

The journal enforces rigorous peer evaluation with a publication frequency of Semimonthly, an annual output of approximately 266 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,641 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Ltd
Publication Language
English
Frequency
Semimonthly
Founding Year
1996
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 35e3353d-f5ec-42f8-b3b5-c89f2b2630de
Database Updated: 2026-09-28